WXKL was proved to attenuate sympathetic atrial fibrillation induced by adrenergic activation with the mechanism of modulating neurohormones by inhibiting calmodulin (CaM) expression and ryanodine receptor 2 (RYR2) phosphorylation [19]. The gene discussed is RYR2; the disease is atrial fibrillation.